Inhibition of cyclooxygenase but not nitric oxide synthase influences effects on the human omental artery of the thromboxane A(2) mimetic U46619 and 17 beta-estradiol
Yp. Vedernikov et al., Inhibition of cyclooxygenase but not nitric oxide synthase influences effects on the human omental artery of the thromboxane A(2) mimetic U46619 and 17 beta-estradiol, AM J OBST G, 185(1), 2001, pp. 182-189
OBJECTIVE: These experiments were performed to study the influence of endot
helial factors on the contractile effect of the thromboxane A(2) analog U46
619 and on the relaxant action of 17 beta -estradiol on isolated human omen
tal arteries from nonpregnant women, women with normal pregnancies, and wom
en with preeclampsia.
STUDY DESIGN: Arterial rings (3 mm) with or without endothelium were suspen
ded in organ chambers filled with Krebs buffer, 37 degreesC, aerated with 5
% carbon dioxide in air, pH approximately 7.4, for isometric tension record
ing. Rings were incubated with indomethacin, N-omega-nitro-L-arginine, or 1
7p-estradiol, alone or in combination. The concentration that produced 50%
of maximal effect, the area under the curve, and the maximal effect of U466
19, normalized with respect to a reference contraction in response to potas
sium chloride, were compared.
RESULTS: Neither indomethacin nor N-omega-nitro-L-arginine changed the basa
l tone of omental artery rings. Neither Nw-nitro-L-arginine nor removal of
the endothelium affected either the contractile action of U46619 or the rel
axant action of 17p-estradiol. In contrast, indomethacin potentiated the co
ntractile effect of U46619 and abolished the inhibitory effect of 17p-estra
diol in rings from all three groups. The effects of U46619 and 17 beta -est
radiol were significantly less in rings from women with normal pregnancy th
an in those from women with preeclampsia. Tissues from women with preeclamp
sia demonstrated the highest contractile response to U46619.
CONCLUSION: The inhibitory effect of 17 beta -estradiol is not due to incre
ased production of endothelial nitric oxide but rather involves inhibitory
products of the cyclooxygenase pathway, The effect of indomethacin may resu
lt from inhibited production or release of eicosanoids or from sensitizatio
n of thromboxane A(2) receptors.